HEC-921

N/A

Report date: 2025/07/08 16:57:12

Base Information

Drug NameHEC-921
Drug Alias NameHEC-921
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Lymphocyte antigen 6 complex locus protein G6d sensitizersAnti-Tumor necrosis factor receptor superfamily member 9
TargetsLymphocyte antigen 6 complex locus protein G6dTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHEC Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHEC Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A